Precision BioSciences Inc expected to post a loss of $1.50 a share - Earnings Preview

Precision Biosciences

30/07/2024 19:44

* Precision BioSciences Inc  DTIL.OQ   DTIL.O  is expected
to show
a fall in quarterly revenue when it reports  results on August 1
for the period ending June 30 2024
    * The Durham North Carolina-based  company is expected to
report a
55.2% decrease in revenue to $8.856 million from $19.79 million
a year ago, according to the mean estimate from 4 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Precision BioSciences
Inc is
for a loss of $1.50 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Precision
BioSciences Inc is $30.00​, above​ its last closing price
of $10.00. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jan. 1 0001   -2.01       -2.05      -0.35     Beat    81.7
 Dec. 31 0001              -2.05      -4.06     Missed  -98.3
 Sep. 30 2023              -4.87      -2.10     Beat    56.9​
 Jan. 1 0001   -7.52       -7.32      -6.90     Beat    59
 ​​Mar.        -6.80       -6.78      -6.90     Missed  -1.8
 31 2023                                                
 Jan. 1 0001   -6.48       -6.22      -7.80     Missed  -25.3​
 Jun. 30 2022  -7.63       -7.95      -6.60     Beat    17
 Jan. 1 0001   -12.38      -12.33     -13.80    Missed  -11.9
 This summary was machine generated July 30 at 18:43 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)